![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.00 | 15.50 | 16.50 | 16.00 | 16.00 | 16.00 | 38,250 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 5.63 | 14.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/8/2018 12:27 | Thanks elrico. Are you able to answer my other questions? | ![]() plasybryn | |
08/8/2018 12:21 | Elrampo is a supreme ramper and beggar. | ![]() monkeywench1 | |
08/8/2018 12:20 | Plasybryn - Ref ethics, indeed. For example, when I spoke to SOH some time ago about the issue of toxins in (carbonated)high sugar drinks like cola, he confirmed it would be an issue for the company to use SweetBiotix just as a healthy sugar replacement. I got the impression this was not viable. He instead talked about healthy alternatives aimed at the younger age group (children) as more of a priority. This is why I have always ruled out SweetBiotix being added to Cola or Pepsi, as examples....it just doesn't fit the health tag the company is building its brands around. | elrico | |
08/8/2018 12:14 | ..and a private company. | ![]() polus | |
08/8/2018 12:10 | SP hotting up - buying at 127p now. | ![]() jestercat2 | |
08/8/2018 12:09 | Polus: Re: Cargill - yes, just taken a look - with revenues of $136.7 billion, heavily into agricultural products and with a range of sweetener on offer, I'd say you're bang on the money. | ![]() jestercat2 | |
08/8/2018 12:05 | Cargill.imho. | ![]() dire cons | |
08/8/2018 12:05 | Thanks Elrico and Polus | ![]() jestercat2 | |
08/8/2018 12:04 | elrico: operating ethics are also considered by SOH I believe, which I find very admirable & unsual. OPTI has the chance to change our world and particularly for our children for the better. Bring it on. Especially as we look to financially benefit as well. Out of interest, where did you conduct your interview with SOH and what was the date? Did it get profiled on VOX? Thanks | ![]() plasybryn | |
08/8/2018 11:59 | Cargill, could be a possible candidate.. | ![]() polus | |
08/8/2018 11:55 | Ref SweetBiotix - Like SOH say's, they have been working and or speaking with ALL the major global corps. Nothing is off the table at this stage. SOH has essentially pitted them off against each other. OPTI are in an exceedingly strong position. Don't forget, OPTI may NOT chose the largest corp, they will chose the one's that offers best value and speed to market. | elrico | |
08/8/2018 11:50 | Rayrac - there is a world of difference between what I do and what you do. You pump with hot air, with no fundamental backing and you shout down anyone, even if they ask a pertinent question. Whereas I deal with FACT's (in the main) and seek an answer if I don't know it. Don't blame me if you don't have the cognitive smarts to understand OPTI, that is your failing, not mine. I can only imagine how big Dave would pump OPTI, a company that will be drowning in cash in 2019/20. Will UKOG be around then? Probably, because fools like you never learn. | elrico | |
08/8/2018 11:48 | Re: Elrico interview and this bit: Elric: Continuing with SweetBiotix; you announced two deals with a $10bl revenue company and another $100bl revenues company, as outlined in the RNS; Try as I may, I could not identify a FTSE100 listed company with the level of turnover in the sector I envisaged SweetBiotix to be utilised. When I queried this with you, so said, “you spent weeks negotiating the wording to on the RNS to give sufficient information to investors and meet the needs of the regulator, but not make it easy to discover who it is. This seems to have worked. I know NDA’s are in place, is there anything you can add you could not within an RNS? Stephen O’Hara: Yes, they are $10bl & $100bl companies, but I did not say the $100bl company was a FTSE100, this was your claim. The company is a global supplier of nutritional and agricultural products to companies around the world with an annual turnover exceeding $100bn. Given the extra 'hints' do we now have any possible candidates for the $100bn company? | ![]() jestercat2 | |
08/8/2018 11:13 | I keep reading the SOH interview by Elrico - the hints SOH gives are mind blowing. Any pharma deal is going to an epic game changer. Super excited. | ![]() polus | |
08/8/2018 11:04 | Rampers showing their lack of investment experience. | ![]() monkeywench1 | |
08/8/2018 10:50 | I think it so nice to see OPTI stable at these levels. Shows we have a decent floor in the price whilst we await the anticipated news to come. | ![]() rafboy | |
08/8/2018 10:48 | cmon OPTI hit us with those big guns, must be close now! In the meantime good to see C4XD moving up nicely through the gears. I genuinely think it has the potential to be a 20x bagger within 2-3 years. | ![]() trotterstrading | |
08/8/2018 10:47 | rayrac, Not half as much a relief as it is to us Everything you touch turns to dust | ![]() judijudi | |
08/8/2018 10:42 | Monkey wench You do come across as an embittered old woman,, are you??? | ![]() tony773 | |
08/8/2018 10:42 | That’s a relief! | ![]() rayrac | |
08/8/2018 10:14 | Nobody is asking you too! :) | ![]() judijudi | |
08/8/2018 10:11 | Elrico is good at that too. The ceo isn't bad at it either! Still wouldn’t touch it. | ![]() rayrac | |
08/8/2018 10:09 | As a holder of a few Opti it's great to see the share price do its own talking :) | ![]() judijudi | |
08/8/2018 10:08 | Needs a bit more pumping? | ![]() rayrac |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions